TY - JOUR
T1 - Immediate effects of kinesiotaping on quadriceps muscle strength
T2 - A single-blind, placebo-controlled crossover trial
AU - Vercelli, Stefano
AU - Sartorio, Francesco
AU - Foti, Calogero
AU - Colletto, Lorenzo
AU - Virton, Domenico
AU - Ronconi, Gianpaolo
AU - Ferriero, Giorgio
PY - 2012/7
Y1 - 2012/7
N2 - Objective: To investigate the immediate effects on maximal muscle strength of kinesiotaping (KT) applied to the dominant quadriceps of healthy subjects. Design: Single-blind, placebo-controlled crossover trial. Setting: "Salvatore Maugeri" Foundation. Participants: With ethical approval and informed consent, a convenience sample of 36 healthy volunteers were recruited. Two subjects did not complete the sessions and were excluded from the analysis. Interventions: Subjects were tested across 3 different sessions, randomly receiving 2 experimental KT conditions applied with the aim of enhancing and inhibiting muscle strength and a sham KT application. Main Outcome Measures: Quadriceps muscle strength was measured by means of an isokinetic maximal test performed at 60 and 180 degrees per second. Two secondary outcome measures were performed: the single-leg triple hop for distance to measure limb performance and the Global Rating of Change Scale (GRCS) to calculate agreement between KT application and subjective perception of strength. Results: Compared with baseline, none of the 3 taping conditions showed a significant change in muscle strength and performance (all P > 0.05). Effect size was very low under all conditions (≤0.08). Very few subjects showed an individual change greater than the minimal detectable change. Global Rating of Change Scale scores demonstrated low to moderate agreement with the type of KT applied, but some placebo effects were reported independently of condition. Conclusions: Our findings indicated no significant effect in the maximal quadriceps strength immediately after the application of inhibition, facilitation, or sham KT. These results do not support the use of KT applied in this way to change maximal muscle strength in healthy people.
AB - Objective: To investigate the immediate effects on maximal muscle strength of kinesiotaping (KT) applied to the dominant quadriceps of healthy subjects. Design: Single-blind, placebo-controlled crossover trial. Setting: "Salvatore Maugeri" Foundation. Participants: With ethical approval and informed consent, a convenience sample of 36 healthy volunteers were recruited. Two subjects did not complete the sessions and were excluded from the analysis. Interventions: Subjects were tested across 3 different sessions, randomly receiving 2 experimental KT conditions applied with the aim of enhancing and inhibiting muscle strength and a sham KT application. Main Outcome Measures: Quadriceps muscle strength was measured by means of an isokinetic maximal test performed at 60 and 180 degrees per second. Two secondary outcome measures were performed: the single-leg triple hop for distance to measure limb performance and the Global Rating of Change Scale (GRCS) to calculate agreement between KT application and subjective perception of strength. Results: Compared with baseline, none of the 3 taping conditions showed a significant change in muscle strength and performance (all P > 0.05). Effect size was very low under all conditions (≤0.08). Very few subjects showed an individual change greater than the minimal detectable change. Global Rating of Change Scale scores demonstrated low to moderate agreement with the type of KT applied, but some placebo effects were reported independently of condition. Conclusions: Our findings indicated no significant effect in the maximal quadriceps strength immediately after the application of inhibition, facilitation, or sham KT. These results do not support the use of KT applied in this way to change maximal muscle strength in healthy people.
KW - assessment
KW - kinesiotape
KW - lower limbs
KW - muscle performance
KW - strengthening
UR - http://www.scopus.com/inward/record.url?scp=84864195175&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864195175&partnerID=8YFLogxK
U2 - 10.1097/JSM.0b013e31824c835d
DO - 10.1097/JSM.0b013e31824c835d
M3 - Article
C2 - 22450591
AN - SCOPUS:84864195175
SN - 1050-642X
VL - 22
SP - 319
EP - 326
JO - Clinical Journal of Sport Medicine
JF - Clinical Journal of Sport Medicine
IS - 4
ER -